Duke University Patent Portfolio Statistics

Duke University

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Duke University look like?

Total Applications: 2,282
Granted Patents: 1,228
Grant Index 68.83 %
Abandoned/Rejected Applications: 556 (31.17%)
In-Process Applications: 494
Average Grant Time: 3.21 Years
Average Office Actions: 1.92

Which Technology Area Duke University is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1648 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 124
Opap Parked GAU 95
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 65
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 60
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 55

How many patents are Duke University filing every year?

Year Total Applications
2022 1*
2021 64*
2020 126
2019 142
2018 154

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Duke University in USPTO?

Publication number: US20210386799A1
Application number: 17/279,386

Abstract:
In certain aspects, described herein are methods, bacteria, and compositions for the treatment of bacterial infections. Specifically, bacteria that can upregulate antimicrobial peptides, e.g., Reg3, within a subject have been identified and methods of using such bacteria to treat infections is described.

Publication date: 2021-12-16
Applicant: Duke University
Inventors: K Neeraj Surana


Publication number: US20210395342A1
Application number: 17/464,168

Abstract:
Provided herein are peptides that exhibit ApoE biological activity, as well as compositions and pharmaceutical formulations that include the peptides. The peptides, compositions, and methods disclosed herein have broad applications as they can be used to treat a broad spectrum of injury, diseases, disorders, and clinical indications.

Publication date: 2021-12-23
Applicant: Duke University
Inventors: Daniel Laskowitz T


Publication number: US20210395754A1
Application number: 17/464,474

Abstract:
The present disclosure provides methods and compositions for the treatment of cancer. In some aspects, the present disclosure provides splice-switching oligonucleotides that downregulate AR or EGFR expression and methods of using these splice-switching oligonucleotides to treat cancer.

Publication date: 2021-12-23
Applicant: Duke University
Inventors: Brendon Patierno


How are Duke University’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/279,386 Methods And Compositions To Treat And Prevent Infection Application Undergoing Preexam Processing OPAP Central, Docket
17/464,168 Peptide Compounds For Suppressing Inflammation Docketed New Case – Ready for Examination OPAP Central, Docket
17/464,474 Splice-Switching Oligonucleotides And Methods Of Use Docketed New Case – Ready for Examination OPAP Central, Docket
17/458,019 Inhibitors Of Complement Factor H Docketed New Case – Ready for Examination OPAP Central, Docket
17/432,011 Compositions And Methods For The Treatment Of Genetic Diseases Sent to Classification contractor OPAP Central, Docket